Sanofi claims that it’s hydroxychloroquine tablets have been counterfeited. Casts doubts on efficacy trials.
The Federal Commission for the Protection against Sanitary Risks (Cofepris) issued a health alert for the counterfeiting of the drug hydroxychloroquine , marketed under the name Plaquenil.